APOE and HIV-associated neurocognitive disorder: ApoE4, in addition to its involvement in Alzheimer’s disease [7–10] and cerebrovascular disease [11], is known to enhance HIV-1 infection [12], accelerate HIV-1 disease progression [12, 13], and increase the incidence of HIV-1-associated neurocognitive disorders (HAND) [14, 15].